Evidence map›Paper›PMID 37161460›Full record

ArticleHarm reduction journal2023

The impact of JUUL market entry on cigarette sales: evidence from a major chain retailer in Canada.

Yingying Xu, Anindya Sen, Tengjiao Chen, Christopher M Harris, Shivaani Prakash

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Harm reduction journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yingying XuJUUL Labs, Inc., Washington, DC, USA.
Anindya SenDepartment of Economics, University of Waterloo, Waterloo, Canada.
Tengjiao ChenJUUL Labs, Inc., Washington, DC, USA. tengjiaochen@gmail.com.
Christopher M HarrisJUUL Labs, Inc., Washington, DC, USA.
Shivaani PrakashJUUL Labs, Inc., Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElectronic nicotine delivery systems (ENDS), such as the JUUL system, are nicotine products for adults who currently smoke cigarettes but are looking for an alternative to combustible cigarettes. Sales of ENDS products were legislatively acknowledged and authorized federally in Canada with the Royal Assent of the Tobacco and Vaping Products Act in 2018.

methodsWith the unique dataset from a major chain retailer in Canada, we evaluated the impacts of JUUL market entry on cigarette sales across Canada from January 2017 to August 2019 using two-way fixed effects panel regression models by leveraging on the entry time variation at the city level. We conducted various robustness checks and a permutation test to validate our results.

resultsOur estimates suggested that JUUL market entry was, on average, significantly correlated with a 1.65% per-month decrease in cigarette sales during the initial months, and with a potentially larger impact on urban areas. Our results were robust across various specifications and tests. These findings implied that JUUL and combustible cigarettes act as economic substitutes during the study time period in Canada.

conclusionsThese results suggested that local availability of ENDS products, such as JUUL, has the potential to reduce local cigarette consumption.

Indexed as

Tobacco ProductsAdultCanadaCommerceHumansNicotineNicotineCigarette and vaping product sales in CanadaElectronic nicotine delivery systemsJUULMarket entry

Identifiers

PMID37161460
PMCPMC10170713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.